{"disease":{"id":"haemorrhagic-shock","name":"haemorrhagic shock"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04561050","title":"Prediction of Massive Transfusion in Trauma Patients","phase":"","overall_status":"COMPLETED","enrollment_count":13222,"lead_sponsor_name":"Centre Hospitalier Universitaire Vaudois","has_results":false},{"nct_id":"NCT05449834","title":"Fibrinogen Early In Severe Trauma StudY II","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"Australian and New Zealand Intensive Care Research Centre","has_results":false},{"nct_id":"NCT06891131","title":"Implementation of an Empiric Transfusion Bundle for Out of Hospital Patients With Haemorrhagic Shock","phase":"","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Medical University of Graz","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}